Self-assembling peptide nanofiber scaffolds, platelet-rich plasma, and mesenchymal stem cells for injectable bone regeneration with tissue engineering

Journal of Craniofacial Surgery

Volumn 20, Issue 5, 2009, Pages 1523-1530

  Yoshimi, Ryoko ^a   Yamada, Yoichi ^b   Ito, Kenji ^b   Nakamura, Sayaka ^a   Abe, Akihiro ^a   Nagasaka, Tetsuro ^a   Okabe, Kazuto ^a   Kohgo, Tomoyuki ^a   Baba, Shunsuke ^c   Ueda, Minoru ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

Bone regeneration; Mesenchymal stem cells (MSCs); Platelet rich plasma (PRP); PuraMatrix (PM); Tissue engineering and regenerative medicine

Indexed keywords

MOLECULAR SCAFFOLD; NANOFIBER; NANOMATERIAL; PEPTIDE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE REGENERATION; CONTROLLED STUDY; DOG; MANDIBLE; MATERIALS TESTING; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING;

ALANINE; ANIMALS; ARGININE; ASPARTIC ACID; BIOCOMPATIBLE MATERIALS; BONE DENSITY; BONE MARROW; BONE REGENERATION; CELLS, CULTURED; DOGS; HYDROGELS; INJECTIONS; MANDIBLE; MANDIBULAR DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICROSCOPY, ELECTRON, SCANNING; NANOFIBERS; OSTEOGENESIS; PEPTIDES; PLATELET-RICH PLASMA; RANDOM ALLOCATION; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 70349671748     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3181b09b7e     Document Type: Article

References (32)

1. Wiltfang J, Merten HA, Schlegel KA, et al. Degradation characteristics of β and A tri-calcium-phosphate (TCP) in minipigs. J Biomed Mater Res 2002;63B:115-121 (Pubitemid 34263854)
2. Zerbo IR, Bronckers ALJJ, de Lange G, et al. Localisation of osteogenic and osteoclastic cells in porous A-tricalcium phosphate particles used for human maxillary sinus floor elevation. Biomaterials 2005;26:1445-1451
3. Bilkay U, Alper M, Celik N, et al. Comparing the osteogenic capacities of bone substitutes: hydroxyapatite, high-density porous: polyethylene, and bone collagen: a biochemical and histological analysis. J Craniofacial Surg 2004;15:585-593
4. Yoshimoto H, Shin YM, Terai H, et al. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 2003;24:2077-2082 (Pubitemid 36298779)
5. Xu CY, Inai R, Kotaki M, et al. Aligned biodegradable nanofibrous structure: a potential scaffold for blood vessel engineering. Biomaterials 2004;25:877-886 (Pubitemid 37371995)
6. Li W-J, Laurencin CT, Caterson EJ, et al. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res 2002;60A:613-621 (Pubitemid 34492600)
7. Hardy RH, Kania R, Verliac S, et al. Infection following the use of porous hydroxyapatite ceramic as a bone defect filler in articular fractures. Eur J Orthop Surg Traumatol 1997;7:63-67 (Pubitemid 127720682)
8. Matic DB, Manson PN. Biomechanical analysis of hydroxyapatite cement cranioplasty. J Craniofacial Surg 2004;15:415-422
9. Zagris N. Extracellular matrix in development of the early embryo. Micron 2001;32:427-438 (Pubitemid 32062531)
10. Holmes TC. Novel peptide-based biomaterial scaffolds for tissue engineering. Trends Biotechnol 2002;20:16-21 (Pubitemid 34015904)
11. Yokoi H, Kinoshita T, Zhang S. Dynamic reassembly of peptide RADA16 nanofiber scaffold. Proc Natl Acad Sci U S A 2005;102:8414-8419 (Pubitemid 40862750)
12. Holmes TC, de Lacalle S, Su X, et al. Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds. Proc Natl Acad Sci U S A 2000;97:6728-6733 (Pubitemid 30412782)
13. Kisiday J, Jin M, Kurtz B, et al. Self-assembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division: Implications for cartilage tissue repair. Proc Natl Acad Sci U S A 2002;99:9996-10001 (Pubitemid 34831161)
14. Zhang S, Holmes TC, DiPersio CM, et al. Self-complementary oligopeptide matrices support mammalian cell attachment. Biomaterals 1995;16:1385-1393
15. Semino CE, Merok JR, Crane GG, et al. Functional differentiation of hepatocyte-like spheroid structures from putative liver progenitor cells in three-dimensional peptide scaffolds. Differentiation 2003;71:262-270
16. Zhang S, Zhao X. Design of molecular biological materials using peptide motifs. J Mater Chem 2004;14:2082-2086
17. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-926
18. Lavik E, Langer R. Tissue engineering: current state and perspectives. Appl Microbiol Biotechnol 2004;65:1-8 (Pubitemid 39044304)
19. Cancedda R, Bianchi G, Derubeis A, et al. Cell therapy for bone disease: a review of current status. Stem Cells 2003;21:610-619 (Pubitemid 37444117)
20. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma, growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol 1998;85:638-646
21. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 2001;10:225-228
22. Zhang S. Fabrication of novel biomaterials through molecular self-assembly. Nature Biotechnol 2003;21:1171-1178 (Pubitemid 37186173)
23. Mendes SC, Tibbe JM, Veenhof M, et al. Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells. J Mater Sci Mater Med 2004;15:1123-1128 (Pubitemid 39491717)
24. Sun-Woong K, Lee JS, Park MS, et al. Enhancement of in vivo bone regeneration efficacy of human mesenchymal stem cells. J Microbiol Biotechnol 2008;18:975-982
25. Nakajima T, Iizuka H, Tsutsumi S, et al. Evaluation of posterolateral spinal fusion using mesenchymal stem cells. Spine 2007;32:2432-2436
26. Xia Z, Locklin RM, Triffitt JT. Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice. Eur J Cell Biol 2008;87:353-364
27. Ohgushi H, Dohi Y, Katsuda T, et al. Osteogenic differentiation of marrow stromal cells in porous hydroxyapatite ceramics. J Biomed Mater Res 1993;27:1401-1407 (Pubitemid 23312631)
28. Hosseinkhani H, Hosseinkhani M, Tian F, et al. Osteogenic differentiation of mesenchymal stem cells in self-assembled peptide-amphiphile nanofibers. Biomaterials 2006;27:4079-4086
29. Yamada Y, Ueda M, Hibi H, et al. Translational research for injectable tissue-engineered bone regeneration using mesenchymal stem cells and platelet-rich plasma: from basic research to clinical case study. Cell Transplant 2004;13:343-355 (Pubitemid 39163079)
30. Yamada Y, Nakamura S, Ito K, et al. Injectable tissue-engineered bone using autogenous bone marrow derived stromal cells for maxillary sinus augmentation: clinical application report - from 2 to 6 years follow up. Tissue Eng 2008;14:1699-1707
31. Yamada Y, Ueda M, Naiki T, et al. Autogenous injectable bone for regeneration with mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) - tissue-engineered bone regeneration. Tissue Eng 2004;10:955-964 (Pubitemid 38880414)
32. Ito K, Yamada Y, Nagasaka T, et al. Osteogenic potential of injectable tissue-engineered bone: a comparison among autogenous bone, bone substitute (Bio-Oss®), platelet-rich plasma (PRP), and tissue-engineered bone with respect to their mechanical properties and histological findings. J Biomed Mater Res 2005;73A:63-72 (Pubitemid 40354824)